Keyphrases
Acute Lymphoblastic Leukemia
100%
Acute Myeloid Leukemia
79%
Leukemia
78%
CD19
53%
Ewing Sarcoma Family of Tumors
48%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
48%
Pediatric
42%
CD34+
40%
Childhood Acute Lymphoblastic Leukemia
38%
SCID Mice
33%
Tumor
29%
Stem Cell Population
29%
Engraftment
29%
Acute Leukemia
28%
BCP-ALL
27%
Leukemia Patients
27%
Immune-deficient Mice
27%
Hematopoietic Stem Cell Transplantation
26%
Relapsed or Refractory
25%
Bone Marrow
25%
Chimeric Antigen Receptor T Cells (CAR-T)
24%
Stem Cell Transplantation
24%
Stem Cells
23%
Tumor Cells
21%
Transplantation
21%
RAS Pathway
21%
Childhood Leukemia
21%
Immunophenotyping
20%
High Risk
20%
Leukemic Stem Cells
20%
T Cells
20%
In Vivo Model
20%
Drug Development
19%
Older Adults
18%
Hematopoietic Cells
18%
Flow Cytometric
18%
Event-free Survival
18%
Acute Lymphoblastic Leukemia Cells
18%
Minimal Residual Disease
18%
Farber Disease
17%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
17%
Cell Population
16%
Gene Therapy
16%
Leukemic Cells
16%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Tumor Cell Lines
15%
Selumetinib
15%
Immunophenotypic Profile
14%
Children with Cancer
14%
Pediatric Cancer
14%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
85%
Acute Myeloid Leukemia
70%
Pediatrics
53%
Leukemia
43%
Stem Cell
41%
Neoplasm
36%
B Cell
33%
Precursor
28%
Acute Myelogenous Leukemia
26%
Hematopoietic Stem Cell Transplantation
26%
Cell Population
23%
Immunotherapy
22%
T Cell
21%
Xenograft
21%
Adolescence
20%
Chemotherapy
20%
Disease
20%
SCID Mouse
20%
Ewing Sarcoma
19%
Metastatic Carcinoma
18%
Farber Disease
17%
Down Syndrome
17%
Clinical Trial
17%
Stem Cell Therapy
16%
Oncology
16%
Transplantation
16%
Malignant Neoplasm
15%
Central Nervous System
15%
Cancer
15%
Pediatric Cancer
14%
Allogeneic Hematopoietic Stem Cell Transplantation
14%
Leukemia in Children
13%
Childhood Cancer
13%
Hematopoietic Cell
13%
Allogeneic Stem Cell Transplantation
12%
Positron Emission Tomography-Computed Tomography
12%
Whole Body PET
12%
Event Free Survival
11%
Auer Rod
11%
Personalized Medicine
11%
3 Hydroxyephedrine
11%
Normal Stem Cell
11%
Dexamethasone
11%
Iodine 123
11%
Radioactive Tracer
11%
Single Photon Emission Computed Tomography-Computed Tomography
11%
(3 Iodobenzyl)guanidine
11%
Sympathetic Nervous System
11%
Carbon 11
11%
Immunity
10%
Immunology and Microbiology
Stem Cell
81%
CD34
62%
CD19
51%
B Cell
48%
Precursor
47%
Myeloid
46%
Cell Population
32%
T Cell
32%
Engraftment
30%
SCID Mouse
30%
Hematopoietic Cell
30%
Tumor Cell
27%
Immunotherapy
25%
Allogeneic Stem Cell Transplantation
24%
Stem Cell Transplantation
24%
Leukemia Cell
24%
Hematopoiesis
23%
Lineages
22%
Cytokine
21%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Central Nervous System
17%
Epstein Barr Virus
16%
Event Free Survival
16%
Xenograft
15%
Hematopoietic Stem Cell Transplantation
14%
Tumor Cell Line
14%
Cell Subpopulation
14%
Chimera
13%
Cancer Stem Cell
13%
Cell Level
12%
Immunology
12%
Human Cell
12%
NOD SCID Mouse
11%
Cell Transplantation
11%
Autoimmune Hemolytic Anemia
11%
Adolescence
11%
Conditioning
11%
Cell Adhesion Proteins
9%
Bone Marrow Cell
9%
CD28
9%
Survival Rate
9%
Cell Death
8%
High Risk Population
8%
DNA Content
8%
CD38
8%
Maturation
8%
CD11a
7%
Antigen Expression
7%
Immunity
7%
T Cell Receptor
7%